At Providence Cancer Institute, patients and families are offered extensive cancer services, including diagnostic imaging, state-of-the-art treatments, nationally-renowned research, and counseling and support. Doctors, surgeons, nurses, researchers, patient advocates, and other caregivers work together to treat cancer aggressively and ensure that no person has to face the challenge of a cancer diagnosis alone.
The institute’s comprehensive and compassionate cancer care includes:Skilled cancer specialists who collaborate on diagnosis and treatment.State-of-the art cancer therapies, including personalized medicine.
Access to clinical trials, including one of the largest programs for early-phase cancer clinical studies on the West Coast.
Integrative medicine to ease symptoms.
A nurse navigator to guide all aspects of care.
Cancer genetics experts, oncology social workers, and cancer support groups.
A cancer survivors’ clinic.
Website: Providence Cancer InstituteContact: 503-215-6014
A Phase II Study of Ribociclib And Endocrine Treatment of Physician’s Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)
BRIDGET: Secondary BRain metastases prevention after Isolated intracranial progression on Trastuzumab/Pertuzumab or T-DM1 in patients with aDvanced human epidermal Growth factor receptor 2+ brEast cancer with the addition of Tucatinib
A Phase II, Single Arm, Open Label, Multi-center Trial of Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Previously Untreated Locally Advanced, Resectable, HPV Mediated Oropharynx Cancer
A Randomized Phase II Trial of Adjuvant Pembrolizumab Versus Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
